Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit Journal Article
| Authors: | Pastores, S. M.; Goldman, D. A.; Shaz, D. J.; Kostelecky, N.; Daley, R. J.; Peterson, T. J.; Tan, K. S.; Halpern, N. A. |
| Article Title: | Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit |
| Abstract: | BACKGROUND: The objective of this study was to evaluate the short-term and long-term outcomes of adult patients with hematologic malignancies who received chemotherapy in the intensive care unit (ICU). METHODS: This was a retrospective, single-center study comparing the outcomes of patients with hematologic malignancies who received chemotherapy in the ICU with a matched cohort of ICU patients who did not receive chemotherapy. Conditional logistic regression and shared-frailty Cox regression were used to assess short-term (ICU and hospital) mortality and death by 12 months after hospital discharge, respectively. RESULTS: One hundred eighty-one patients with hematologic malignancies received chemotherapy in the ICU. The ICU and hospital mortality rates were 25% and 42% for chemotherapy patients and 22% and 33% for non-chemotherapy patients, respectively. Higher severity of illness scores on ICU admission were significantly associated with higher ICU mortality (odds ratio, 1.07; P <.001) and hospital mortality (odds ratio, 1.05; P ≤.001). Six-month and 12-month survival estimates posthospital discharge were 58% and 50%, respectively. Compared with the matched cohort of patients who did not receive chemotherapy, those who did receive chemotherapy had a significantly longer length of stay in the ICU (median, 6 vs 3 days; P <.001) and in the hospital (median, 22 vs 14 days; P =.024). In multivariable analysis, the patients who received chemotherapy in the ICU had a trend toward a higher risk of dying by 12 months (hazard ratio, 1.45; P =.08). CONCLUSIONS: Short-term mortality was similar among patients with hematologic malignancies who did and did not receive chemotherapy in the ICU, although patients who received chemotherapy had increased resource utilization. These results may inform ICU triage and goals-of-care discussions with patients and their families regarding outcomes after receiving chemotherapy in the ICU. Cancer 2018;124:3025-36. © 2018 American Cancer Society. © 2018 American Cancer Society |
| Keywords: | chemotherapy; intensive care unit; outcomes; hematologic; cancer |
| Journal Title: | Cancer |
| Volume: | 124 |
| Issue: | 14 |
| ISSN: | 0008-543X |
| Publisher: | Wiley Blackwell |
| Date Published: | 2018-07-15 |
| Start Page: | 3025 |
| End Page: | 3036 |
| Language: | English |
| DOI: | 10.1002/cncr.31409 |
| PROVIDER: | scopus |
| PUBMED: | 29727916 |
| PMCID: | PMC6119607 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 1 August 2018 -- Source: Scopus |
Altmetric
Citation Impact
Related MSK Work